HeimBICO • STO
add
BICO Group AB
Við síðustu lokun
30,00 kr.
Dagbil
30,06 kr. - 35,70 kr.
Árabil
29,32 kr. - 72,30 kr.
Markaðsvirði
2,99 ma. SEK
Meðalmagn
177,24 þ.
V/H-hlutf.
-
A/V-hlutfall
-
Aðalkauphöll
STO
Í fréttum
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
(SEK) | jún. 2024info | Breyting á/á |
---|---|---|
Tekjur | 534,00 m. | -0,56% |
Rekstrarkostnaður | 324,90 m. | 86,51% |
Nettótekjur | -77,90 m. | 81,64% |
Hagnaðarhlutfall | -14,59 | 81,53% |
Hagnaður á hvern hlut | — | — |
EBITDA | 35,50 m. | -93,03% |
Virkt skatthlutfall | 8,49% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
(SEK) | jún. 2024info | Breyting á/á |
---|---|---|
Reiðufé og skammtímafjárfestingar | 687,60 m. | -0,45% |
Heildareignir | 5,70 ma. | -37,50% |
Heildarskuldir | 2,72 ma. | -11,43% |
Eigið fé alls | 2,97 ma. | — |
Útistandandi hlutabréf | 70,57 m. | — |
Eiginfjárgengi | 0,72 | — |
Arðsemi eigna | -2,15% | — |
Ávöxtun eigin fjár | -2,50% | — |
Peningaflæði
Breyting á handbæru fé
(SEK) | jún. 2024info | Breyting á/á |
---|---|---|
Nettótekjur | -77,90 m. | 81,64% |
Handbært fé frá rekstri | -50,90 m. | -6,71% |
Reiðufé frá fjárfestingum | -22,60 m. | 80,11% |
Reiðufé frá fjármögnun | -27,80 m. | -424,53% |
Breyting á handbæru fé | -108,10 m. | 35,88% |
Frjálst peningaflæði | -91,89 m. | -126,44% |
Um
Bico Group is a bioconvergence startup that designs and supplies technologies and services to enhance biology research. It focuses on commercializing technologies for life science research as well as bioprinting, and its products often combine capabilities in artificial intelligence, robotics, multiomics, and diagnostics.
Bico Group began by producing bio-inks and bioprinters for culturing different cell types to enable applications like patient-derived implants. Bico Group was the first company to provide a standardized bio-ink product for sale over the internet.
The company has ongoing collaborations with organizations including AstraZeneca, MedImmune, MIT and Takara Bio, and its bioprinters are used for research at Harvard University, Merck, Novartis, the U.S. Army, Toyota, Johnson & Johnson and more. Wikipedia
Framkvæmdastjóri
Stofnsett
27. jan. 2016
Vefsvæði
Starfsfólk
832